Cargando…
Ex Vivo Expansion of Murine MSC Impairs Transcription Factor-Induced Differentiation into Pancreatic β-Cells
Combinatorial gene and cell therapy as a means of generating surrogate β-cells has been investigated for the treatment of type 1 diabetes (T1D) for a number of years with varying success. One of the limitations of current cell therapies for T1D is the inability to generate sufficient quantities of f...
Autores principales: | Gerace, Dario, Martiniello-Wilks, Rosetta, Habib, Rosaline, Ren, Binhai, Nassif, Najah Therese, O'Brien, Bronwyn Anne, Simpson, Ann Margaret |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431458/ https://www.ncbi.nlm.nih.gov/pubmed/30956666 http://dx.doi.org/10.1155/2019/1395301 |
Ejemplares similares
-
Luciferase-based reporting of suicide gene activity in murine mesenchymal stem cells
por: Gerace, Dario, et al.
Publicado: (2019) -
CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?
por: Gerace, Dario, et al.
Publicado: (2017) -
Pancreatic Transdifferentiation and Glucose-Regulated Production of Human Insulin in the H4IIE Rat Liver Cell Line
por: Ren, Binhai, et al.
Publicado: (2016) -
Pancreatic Transdifferentiation Using β-Cell Transcription Factors for Type 1 Diabetes Treatment
por: Mahoney, Alexandra L. G., et al.
Publicado: (2022) -
Use of a Hybrid Adeno-Associated Viral Vector Transposon System to Deliver the Insulin Gene to Diabetic NOD Mice
por: La, Que T., et al.
Publicado: (2020)